Posted in | News | Business | Clean Technology

Endicott Biofuels Signs Agreement with KMTEX to Construct Biorefinery in Texas

Endicott Biofuels, LLC (EBF) has signed an agreement with KMTEX Ltd. (KMTEX) to construct a 30-million gallon-per-year biorefinery in Port Arthur, Texas, that will employ EBF's proprietary technology for the production of high-purity G2 Clear™ biodiesel.

KMTEX will host EBF as well as provide certain construction and operational services. Equity funding will come from Haddington Ventures, LLC, and construction is expected to begin in late January 2011.

"Our extensive specialty chemical processing capabilities in Port Arthur are well-suited to complement Endicott's unique production of biodiesel," said Artie McFerrin, President of KMTEX. "We are excited to begin this fruitful long-term relationship."

G2 Clear is Endicott's high-purity, high-quality biodiesel made from waste fats, oils and greases. This patent-protected process is capable of consuming any waste fat or oil in any proportion. EBF will use inedible feedstocks to help the U.S. meet the renewable fuel targets defined in the federal Renewable Fuel Standard and reduce dependence on foreign sources of crude oil.

"We are extremely pleased to establish this new business relationship with KMTEX and with the opportunity to locate our biorefinery here in Port Arthur," said EBF's CEO David Robinson. "Our G2 Clear has demonstrated the ability to exceed ASTM specifications for biodiesel using 100 percent waste materials and will have sub-60 second cold soak performance and very low carbon intensity, which means a fuel that is both reliable and environmentally cleaner than its competitors."

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.